WesBanco Bank’s Novo Nordisk NVO Stock Holding History

WesBanco Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Sell	5,887 -2,033	-26%	-$87.3K	0.01%	599
2026 Q1	$291K	Sell	7,920 -9,633	-55%	-$456K	0.01%	575
2025 Q4	$893K	Sell	17,553 -58,967	-77%	-$3.02M	0.02%	388
2025 Q3	$4.25M	Sell	76,520 -97,165	-56%	-$5.69M	0.12%	142
2025 Q2	$12M	Sell	173,685 -4,116	-2%	-$280K	0.36%	66
2025 Q1	$12.3M	Buy	177,801 +74,685	+72%	+$6.17M	0.43%	56
2024 Q4	$8.87M	Buy	103,116 +19,224	+23%	+$2.08M	0.3%	77
2024 Q3	$9.99M	Buy	83,892 +21,904	+35%	+$2.92M	0.34%	73
2024 Q2	$8.85M	Buy	61,988 +23,796	+62%	+$3.15M	0.33%	72
2024 Q1	$4.9M	Buy	+38,192	New	+$4.55M	0.19%	121
2023 Q3	–	Sell	-6,618	Closed	-$535K	–	581
2023 Q2	$535K	Buy	+6,618	New	+$541K	0.02%	395

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

GIM

Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

WesBanco Bank's NVO Position: Q2 2026 in Review

WesBanco Bank reduced its Novo Nordisk (NVO) stake by 26% in Q2 2026, selling an estimated $87.3K and leaving 5,887 shares worth $282K. The position accounts for 0.01% of the portfolio, ranked #599.

WesBanco Bank first reported a position in NVO in Q2 2023 and has held it in 11 quarters since. The position peaked at $12.3M in Q1 2025. 549 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

WesBanco Bank held 5,887 shares of Novo Nordisk worth $282K as of Q2 2026.
WesBanco Bank sold 2,033 Novo Nordisk shares in Q2 2026, an estimated $87.3K.
Novo Nordisk made up 0.01% of WesBanco Bank's portfolio in Q2 2026, its #599 holding.
WesBanco Bank first reported a position in Novo Nordisk in Q2 2023 and has held it in 11 quarters since.
WesBanco Bank's Novo Nordisk position peaked at $12.3M in Q1 2025.
549 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.